Company · CIK 0001707502 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Solid Biosciences Inc. · SLDB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 MForm 4 → | Jul 7, 4:05 pm EDT | Ian F SmithDirector | 3,440 | — | — | 138,145 | — | |
| Jan 14, 2019 SForm 4 → | Jan 16, 1:07 pm EST | Matthew Bennett ArnoldDirector | 5,000 | $32.00 | $159,982 | 3,386,293 | −0.15% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 8, 4:05 pm EST | Matthew Bennett ArnoldDirector | 5,000 | $30.08 | $150,407 | 3,391,293 | −0.15% | plan? |
| Jan 4, 2019 SForm 4/A → | Jan 10, 4:42 pm EST | Pedro Alvaro AmorrortuChief Operating Officer | 9,000 | $30.07 | $270,619 | 153,746 | −5.53% | plan? |
| Jan 4, 2019 SForm 4 → | Jan 8, 4:05 pm EST | Pedro Alvaro AmorrortuChief Operating Officer | 9,000 | $30.07 | $270,619 | 158,046 | −5.39% | plan? amended |
| Dec 3, 2018 SForm 4/A → | Jan 10, 2019, 4:44 pm EST | Pedro Alvaro AmorrortuChief Operating Officer | 9,000 | $31.06 | $279,534 | 162,746 | −5.24% | plan? |
| Dec 3, 2018 SForm 4 → | Dec 4, 7:05 pm EST | Pedro Alvaro AmorrortuChief Operating Officer | 9,000 | $31.06 | $279,534 | 167,046 | −5.11% | plan? amended |
| Dec 3, 2018 SForm 4 → | Dec 4, 7:01 pm EST | Jorge Armando QuirozChief Medical Officer | 40,150 | $31.21 | $1,253,145 | 228,092 | −15.0% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 20, 6:32 am EST | Jorge Armando QuirozChief Medical Officer | 100 | $34.90 | $3,490 | 268,242 | −0.04% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 20, 6:30 am EST | Juan Andrey ZarurDirector | 100 | $35.00 | $3,500 | 691,105 | −0.01% | plan? |
| Nov 15, 2018 SForm 4/A → | Jan 10, 2019, 4:45 pm EST | Joel Solomon Zev SchneiderSee Remarks | 21,990 | $30.84 | $678,180 | 124,656 | −15.0% | plan? |
| Nov 15, 2018 SForm 4 → | Nov 19, 4:14 pm EST | Ilan GanotCEO & President, Director | 50,000 | $30.84 | $1,541,933 | 1,102,126 | −4.34% | plan? |
| Nov 15, 2018 SForm 4 → | Nov 19, 4:11 pm EST | Joel Solomon Zev SchneiderSee Remarks | 21,990 | $30.84 | $678,180 | 126,656 | −14.8% | plan? amended |
| Nov 15, 2018 SForm 4 → | Nov 19, 4:10 pm EST | Pedro Alvaro AmorrortuChief Operating Officer | 9,000 | $30.83 | $277,478 | 171,746 | −4.98% | plan? |
| Aug 22, 2018 GForm 4 → | Aug 28, 6:07 am EDT | Gilad David Hayeem10% Owner | 35,653 | — | — | 1,948,991 | — | plan? late |
| Jan 30, 2018 PForm 4 → | Feb 1, 7:07 pm EST | Adam KoppelDirector | 300,000 | $16.00 | $4,800,000 | 1,989,444 | +17.8% | plan? |
| Jan 30, 2018 PForm 4 → | Jan 30, 5:43 pm EST | Rajeev M. ShahDirector | 1,000,000 | $16.00 | $16,000,000 | 2,689,444 | +59.2% | plan? |
| Jan 30, 2018 PForm 4 → | Jan 30, 1:05 pm EST | PERCEPTIVE ADVISORS LLC +2Director, 10% Owner | 1,020,000 | $16.22 | $16,546,520 | 3,927,222 | +35.1% | plan? |
| Jan 25, 2018 MForm 4 → | Feb 1, 7:07 pm EST | Adam KoppelDirector | 1,689,444 | — | — | 1,689,444 | — | plan? late |